Redox Biology · 2016 · 49 citations · 34 references
Life SciencesBiochemistryFood ScienceFood ChemistryGreen ChemistryProtein BiochemistryAntioxidant DefenseEnzyme InhibitionFood AntioxidantsLipid OxidationOxidative Damage To BiomoleculesProtein OxidationAmyloid Fibril FormationAmyloid FibrillogenesisAmyloid FibrilsDietary AntioxidantsInhibition Of Amyloid FormationLysozyme ActivityTea OxidationTea Polyphenols
Epigallocatechin gallate (EGCG), the most abundant flavanoid in green tea, is currently being evaluated in the clinic due to its benefits in the treatment of amyloid disorders. Its anti-amyloidogenic effect has been attributed to direct interaction of the intact molecule with misfolded polypeptides. In addition, antioxidant activity is also involved in the anti-amyloidogenic role. The detailed molecular mechanism is still unclear and requires further investigation. In the present study, the kinetics of EGCG oxidation and the anti-amyloidogenic effect of the resultant oxidation substances have been examined. The results indicate that EGCG degrades in a medium at pH 8.0 with a half-life less than 2h. By utilizing lysozyme as an in vitro model, the oxidized EGCG demonstrates a more potent anti-amyloidogenic capacity than the intact molecule, as shown by ThT and ANS fluorescence, TEM determination, and hemolytic assay. The oxidized EGCG also has a stronger disruptive effect on preformed fibrils than the native form. Ascorbic acid eliminates the disruptive role of native EGCG on the fibrils, suggesting that oxidation is a prerequisite in fibril disruption. The results of this work demonstrate that oxidized EGCG plays a more important role than the intact molecule in anti-amyloidogenic activity. These insights into the action of EGCG may provide a novel route to understand the anti-amyloidogenic activity of natural polyphenols.
34
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis
Rakez Kayed, Elizabeth Head, Jennifer L. Thompson et al. · Science · 2003 · 4.1K citations
Human lysozyme gene mutations cause hereditary systemic amyloidosis
Mark B. Pepys, Philip N. Hawkins, David R. Booth et al. · Nature · 1993 · 660 citations